Tomomi Toyonaga

1.4k total citations
24 papers, 1.1k citations indexed

About

Tomomi Toyonaga is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Tomomi Toyonaga has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Surgery. Recurrent topics in Tomomi Toyonaga's work include Metabolism, Diabetes, and Cancer (8 papers), Diabetes and associated disorders (7 papers) and Pancreatic function and diabetes (6 papers). Tomomi Toyonaga is often cited by papers focused on Metabolism, Diabetes, and Cancer (8 papers), Diabetes and associated disorders (7 papers) and Pancreatic function and diabetes (6 papers). Tomomi Toyonaga collaborates with scholars based in Japan, United States and South Korea. Tomomi Toyonaga's co-authors include Eiichi Araki, Kaku Tsuruzoe, Tetsuya Taguchi, Hiroyuki Motoshima, K Yamamura, S Sugai, Tatsuya Kondo, Okio Hino, Masayoshi Shichiri and Motoyuki Igata and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Circulation Research.

In The Last Decade

Tomomi Toyonaga

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomomi Toyonaga Japan 17 521 300 230 225 205 24 1.1k
Zouher Majd France 15 864 1.7× 354 1.2× 256 1.1× 301 1.3× 69 0.3× 24 1.5k
Takuma Kondo Japan 16 651 1.2× 341 1.1× 556 2.4× 211 0.9× 320 1.6× 41 1.4k
Toshio Ogihara Japan 15 578 1.1× 249 0.8× 187 0.8× 72 0.3× 121 0.6× 40 1.6k
Judith Magenheim Israel 15 704 1.4× 544 1.8× 182 0.8× 104 0.5× 302 1.5× 24 1.3k
Carlos M. Rodríguez‐Ortigosa Spain 18 382 0.7× 234 0.8× 113 0.5× 264 1.2× 76 0.4× 37 1.1k
Jose Zavala‐Solorio United States 13 465 0.9× 279 0.9× 156 0.7× 172 0.8× 127 0.6× 18 1.0k
Lucia Russo United States 18 723 1.4× 292 1.0× 284 1.2× 650 2.9× 141 0.7× 33 1.8k
Mitsuru Ono Japan 8 429 0.8× 221 0.7× 707 3.1× 264 1.2× 171 0.8× 11 1.9k
Gábor Firneisz Hungary 18 238 0.5× 187 0.6× 280 1.2× 240 1.1× 99 0.5× 46 977
Adrián Recinos United States 16 499 1.0× 252 0.8× 166 0.7× 190 0.8× 154 0.8× 20 1.7k

Countries citing papers authored by Tomomi Toyonaga

Since Specialization
Citations

This map shows the geographic impact of Tomomi Toyonaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomomi Toyonaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomomi Toyonaga more than expected).

Fields of papers citing papers by Tomomi Toyonaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomomi Toyonaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomomi Toyonaga. The network helps show where Tomomi Toyonaga may publish in the future.

Co-authorship network of co-authors of Tomomi Toyonaga

This figure shows the co-authorship network connecting the top 25 collaborators of Tomomi Toyonaga. A scholar is included among the top collaborators of Tomomi Toyonaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomomi Toyonaga. Tomomi Toyonaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishikawa, Takeshi, Hiroyuki Kinoshita, Keiko Ono, et al.. (2020). Clinical profiles of hyperglycemic crises: A single‐center retrospective study from Japan. Journal of Diabetes Investigation. 12(8). 1359–1366. 7 indexed citations
2.
3.
Murata, Yusuke, Kaku Tsuruzoe, Junji Kawashima, et al.. (2007). IRS-1 transgenic mice show increased epididymal fat mass and insulin resistance. Biochemical and Biophysical Research Communications. 364(2). 301–307. 11 indexed citations
4.
Toyonaga, Tomomi & Eiichi Araki. (2006). [Strategies for the prevention of elderly-onset type 2 diabetes mellitus].. PubMed. 64(1). 140–3. 1 indexed citations
5.
Toyonaga, Tomomi, Tatsuya Kondo, Kunio Matsumoto, et al.. (2005). Enhanced expression of PDX-1 and Ngn3 by exendin-4 during β cell regeneration in STZ-treated mice. Biochemical and Biophysical Research Communications. 327(4). 1170–1178. 71 indexed citations
6.
Nakamaru, Kazuhiko, Kazuya Matsumoto, Tetsuya Taguchi, et al.. (2005). AICAR, an activator of AMP-activated protein kinase, down-regulates the insulin receptor expression in HepG2 cells. Biochemical and Biophysical Research Communications. 328(2). 449–454. 29 indexed citations
7.
Miyamura, Nobuhiro, Kazuya Matsumoto, Tetsuya Taguchi, et al.. (2003). Atypical Bartter Syndrome with Sensorineural Deafness with G47R Mutation of the β-Subunit for ClC-Ka and ClC-Kb Chloride Channels, Barttin. The Journal of Clinical Endocrinology & Metabolism. 88(2). 781–786. 45 indexed citations
8.
Kawashima, Junji, Kaku Tsuruzoe, Hiroyuki Motoshima, et al.. (2003). Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes. Diabetologia. 46(2). 231–240. 44 indexed citations
9.
Hirashima, Yoshiaki, Kaku Tsuruzoe, Shintaro Kodama, et al.. (2003). Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway. Journal of Endocrinology. 179(2). 253–266. 66 indexed citations
10.
Toyonaga, Tomomi, Tatsuya Kondo, Nobuhiro Miyamura, et al.. (2002). Sudden onset of diabetes with ketoacidosis in a patient treated with FK506/tacrolimus. Diabetes Research and Clinical Practice. 56(1). 13–18. 16 indexed citations
11.
12.
Toyonaga, Tomomi, Kaku Tsuruzoe, T. Shirotani, et al.. (2002). Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes. Journal of Endocrinology. 174(2). 309–319. 44 indexed citations
13.
Yoshizato, Kazuaki, T. Shirotani, Noboru Furukawa, et al.. (2001). Identification of a cis-Acting Element and a Novel trans-Acting Factor of the Human Insulin Receptor Gene in HepG2 and Rat Liver Cells. Biochemical and Biophysical Research Communications. 280(2). 428–434. 15 indexed citations
14.
Taguchi, Tetsuya, Hideki Kishikawa, Hiroyuki Motoshima, et al.. (2000). Involvement of bradykinin in acute exercise-induced increase of glucose uptake and GLUT-4 translocation in skeletal muscle: Studies in normal and diabetic humans and rats. Metabolism. 49(7). 920–930. 51 indexed citations
15.
Hattori, Masakazu, Eiji Yamato, Naoto Itoh, et al.. (1999). Cutting Edge: Homologous Recombination of the MHC Class I K Region Defines New MHC-Linked Diabetogenic Susceptibility Gene(s) in Nonobese Diabetic Mice. The Journal of Immunology. 163(4). 1721–1724. 59 indexed citations
16.
Tanahashi, Nobuyuki, Kinya Yokota, Joon Young Ahn, et al.. (1997). Molecular properties of the proteasome activator PA28 family proteins and γ‐interferon regulation. Genes to Cells. 2(3). 195–211. 110 indexed citations
17.
Ishii, Masatoshi, Fumi Tashiro, Shinji Hagiwara, et al.. (1994). Embryonic Expression of MHC Class I Heavy and Light Chains in Transgenic Mice. Endocrine Journal. 41(Supplement). S9–S16. 17 indexed citations
18.
Toyonaga, Tomomi, Okio Hino, S Sugai, et al.. (1994). Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.. Proceedings of the National Academy of Sciences. 91(2). 614–618. 174 indexed citations
19.
Kobori, Shozo, Takayuki Sasahara, Masakazu Sakai, et al.. (1993). Acetyl-low density lipoprotein receptors on rat mesangial cells. Atherosclerosis. 101(2). 177–184. 13 indexed citations
20.
Yamamura, Ken‐Ichi, Toru Miyazaki, Masashi Uno, Tomomi Toyonaga, & Jun‐ichi Miyazaki. (1992). Non-obese diabetic transgenic mouse. Springer Seminars in Immunopathology. 14(2). 115–25. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zouher Majd Breakdown of academic impact, for papers by Takuma Kondo Breakdown of academic impact, for papers by Toshio Ogihara Breakdown of academic impact, for papers by Judith Magenheim Breakdown of academic impact, for papers by Carlos M. Rodríguez‐Ortigosa Breakdown of academic impact, for papers by Jose Zavala‐Solorio Breakdown of academic impact, for papers by Lucia Russo Breakdown of academic impact, for papers by Mitsuru Ono Breakdown of academic impact, for papers by Gábor Firneisz Breakdown of academic impact, for papers by Adrián Recinos
Rankless by CCL
2026